IR@PKUHSC  > 北京大学第一临床医学院  > 临床药理研究所
学科主题临床医学
A Phase II Study of Antofloxacin Hydrochloride, a Novel Fluoroquinolone, for the Treatment of Acute Bacterial Infections
Wang, Jin1; Xiao, Yonghong1; Huang, Wenxiang2; Xu, Nan3; Bai, Chunxue4; Xiu, Qingyu5; Mei, Changlin6; Zheng, Qingshan7
关键词Antofloxacin hydrochloride Levofloxacin hydrochloride Acute exacerbation of chronic bronchitis Acute pyelonephritis
刊名CHEMOTHERAPY
2010
DOI10.1159/000317581
56期:5页:378-385
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Pharmacology & Pharmacy
研究领域[WOS]Oncology ; Pharmacology & Pharmacy
关键词[WOS]DOUBLE-BLIND ; CHRONIC-BRONCHITIS ; ACUTE EXACERBATIONS ; MALE-VOLUNTEERS ; PHARMACOKINETICS ; PYELONEPHRITIS ; CIPROFLOXACIN ; GATIFLOXACIN ; LEVOFLOXACIN
英文摘要

Aims: To evaluate the clinical and bacterial efficacies and the safety of antofloxacin hydrochloride tablets in the treatment of acute exacerbations of chronic bronchitis (AECB) and acute pyelonephritis (AP). Patients and Methods: A randomized, controlled, multicenter, double-blind, double-dummy clinical trial was conducted at 6 hospitals in China. The patients in the investigational group took an oral 400-mg loading dose of antofloxacin on the first day followed by 200 mg daily. Control group patients took 200 mg of levofloxacin orally twice daily for 7-14 days. Results: A total of 284 patients were enrolled into the study, including 140 cases of AECB and 144 cases of AP; 141 patients were in the antofloxacin group and 143 patients were in the levofloxacin group. Two hundred fifty-four patients completed the entire treatment and follow-up and comprised the per-protocol analysis data set; 30 patients were excluded because of informed consent withdrawal, loss to follow-up, protocol violations, or adverse drug events. Treatment was ceased in 3 patients in the antofloxacin group and in 1 patient in the levofloxacin group because of skin rashes, dizziness, or adverse gastrointestinal effects. At the end of the 2-regimen treatment, the observed effectiveness rates for AECB were 90.3 and 87.7% for the treatment and control groups, respectively, and 96.9 and 92.1% for AP. The overall bacterial eradication rates were 95.9 and 92.4%, and drug-related adverse events were observed in 13.1 and 10.1% of patients, respectively. There were no severe adverse effects. No statistical differences in drug efficacy and safety were detected between the 2 treatment groups (p > 0.05). Conclusions: Antofloxacin hydrochloride is an effective and well-tolerated new fluoroquinolone that demonstrates clinical and bacteriological efficacies similar to levofloxacin for the treatment of AECB and AP. Copyright (C) 2010 S. Karger AG, Basel

语种英语
WOS记录号WOS:000283553700005
资助机构Anhui Huanqiu Pharmaceutical Co., Ltd., Bengbu, China
引用统计
被引频次:9[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/61421
专题北京大学第一临床医学院_临床药理研究所
作者单位1.Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
2.Drug Clin Evaluat Ctr Anhui Prov, Wuhu, Peoples R China
3.Sichuan Univ, W China Hosp, Chengdu 610064, Peoples R China
4.Peking Univ, Inst Clin Pharmacol, Hosp 1, Beijing 100191, Peoples R China
5.Chongqing Univ Med Sci, Affiliated Hosp 1, Chongqing, Peoples R China
6.Second Mil Med Univ, Changzheng Hosp, Shanghai, Peoples R China
7.Zhongnan Univ, Xiangya Hosp 3, Changsha, Hunan, Peoples R China
推荐引用方式
GB/T 7714
Wang, Jin,Xiao, Yonghong,Huang, Wenxiang,et al. A Phase II Study of Antofloxacin Hydrochloride, a Novel Fluoroquinolone, for the Treatment of Acute Bacterial Infections[J]. CHEMOTHERAPY,2010,56(5):378-385.
APA Wang, Jin.,Xiao, Yonghong.,Huang, Wenxiang.,Xu, Nan.,Bai, Chunxue.,...&Zheng, Qingshan.(2010).A Phase II Study of Antofloxacin Hydrochloride, a Novel Fluoroquinolone, for the Treatment of Acute Bacterial Infections.CHEMOTHERAPY,56(5),378-385.
MLA Wang, Jin,et al."A Phase II Study of Antofloxacin Hydrochloride, a Novel Fluoroquinolone, for the Treatment of Acute Bacterial Infections".CHEMOTHERAPY 56.5(2010):378-385.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wang, Jin]的文章
[Xiao, Yonghong]的文章
[Huang, Wenxiang]的文章
百度学术
百度学术中相似的文章
[Wang, Jin]的文章
[Xiao, Yonghong]的文章
[Huang, Wenxiang]的文章
必应学术
必应学术中相似的文章
[Wang, Jin]的文章
[Xiao, Yonghong]的文章
[Huang, Wenxiang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。